Remote Patient Monitoring Devices Market - By Product, By Application, By End Use - Global Forecast 2025 - 2034

Remote Patient Monitoring Devices Market Size

The global remote patient monitoring (RPM) devices market was estimated at USD 17 billion in 2024. The market is expected to grow from USD 18.4 billion in 2025 to USD 57.5 billion by 2034 at a CAGR of 13.5% during the forecast period. The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, cancer, chronic kidney diseases (CKD) are significant factors driving the market growth.
 

For instance, in 2021, as per the data from the World Health Organization (WHO), non-communicable disease was responsible for 43 million deaths worldwide among this cardiovascular disease was responsible for at least 19 million deaths followed by cancer with 10 million, chronic respiratory diseases with 4 million. Thus, this alarming statistic highlights the growing need for remote patient monitoring devices to support early detection, continuous management, and timely intervention in managing chronic disorders such as cardiovascular conditions.
 

Furthermore, the rising adoption of remote patient monitoring devices is due to government-backed initiatives that promote digital health transformation, which is a substantial catalyst for the market growth. RPM devices enables real-time health data collection, which allow for an early detection of irregularities and timely interventions.
 

For instance, according to the National Institute of Health (NIH) report, in the U.S. between March 2020 and 2021 the use of RPM devices grew four times among the individuals. RPM devices usage surged during the COVID 19 pandemic across the U.S. Thus, growing disposable income and healthcare expenditure in emerging countries and rising technological advancements in developed nations are the promoting factors that are contributing to the growth of the market.
 

RPM devices are technologically developed tools that allow for the continuous, real-time tracking of patient’s health apart from traditional clinical method. These devices range from wearable sensors to implantable and handheld instruments, which monitor numerous physiological parameters such as heart rate, blood pressure, and blood glucose levels. By using RPM devices, data is transferred wirelessly to healthcare providers, allowing real-time health assessments, increasing patient engagement, and supporting value-based healthcare models.
 

Remote Patient Monitoring Devices Market Trends

• The growing technological advancement in the remote patient monitoring (RPM) devices has revolutionized healthcare in developing countries. Innovations in artificial intelligence in healthcare, which is estimated    to reach USD 281.2 billion by 2032, along with the developments in wearable technology, sensor accuracy, and telehealth integration, have led to more effective and personalized monitoring solutions. 
   
• Internet of Things (IoT) and artificial intelligence (AI) are integrated into modern RPM devices. These technologies allow real-time data collection, analysis and automated decision-making. Thus, AI algorithms can help to predict potential health issues by analyzing data trends, which improves early diagnosis and personalized care.
   
• For example, in January 2024, Blue Spark Technologies launched its first multi-sensor remote patient monitoring platform, VitalTraq, which uses AI driven contactless technologies. It utilizes 30 to 60 second selfie scan, wherein patients, clinicians, and researchers can collect digital measurements, including heart rate variability, blood pressure, and respiratory rate vital signs in a single contactless manner, which set a new standard in patient centered vital sign monitoring.
   
• In addition to this, innovations in wearable technology, which includes smartwatches and fitness trackers, have increased RPM capabilities. These devices continuously monitor vital signs such as heart rate, blood pressure, and glucose levels, which supports valuable data for both patients and healthcare professionals.
   
• For instance, in June 2024, Prevounce Health launched Pylo GL1-LTE, a cellular-connected blood glucose meter which is designed for use in RPM programs for diabetes management.
   
• Furthermore, advancement in biosensors technology have led to more accurate and reliable monitoring devices. Modern sensors can track wide range of physiological parameters such as blood oxygen levels, respiratory rates, and even sleep patterns.
   
• A notable example for this is BioIntelliSense’s BioButton, a multi-Patient wearable BioDashboard system, that offers continuous patient monitoring through advanced biosensor technology. Thus, this technological advancement is contributing to the growth of the market.
   

Remote Patient Monitoring Devices Market Analysis

In 2021, the global market was valued at USD 15 billion. The following year, it saw a slight decrease to USD 14.8 billion, and by 2023 and 2024, the market further climbed to USD 15.8 billion, and USD 17 billion respectively. Based on product, the market is divided into cardiac monitoring devices, blood pressure monitors, neurological monitoring devices, multiparameter monitoring devices, blood glucose monitoring devices, fetal and neonatal monitoring devices, sleep monitoring devices, and other monitoring devices. The cardiac monitoring devices segment held revenues of USD 4 billion in the year 2024 and the segment is poised for significant growth at a CAGR of 13.8% during the forecast period.
 

• The rising technological advancement has significantly heightened the demand for cardiac monitoring devices, which leads to more precise and reliable remote patient monitoring (RPM). Innovations in RPM devices such as the integration of artificial intelligence in healthcare and development of advanced sensors have improved the accuracy of these devices in tracking vital cardiac metrics.
   
• For instance, the LINQ II, an insertable cardiac monitor by Medtronic uses AccuRhythm, an AI algorithm to detect arrhythmias with high precision.
   
• Similarly, Abbott’s Confirm Rx, is insertable cardiac monitor (ICM) with SharpSense technology, which transfers data wirelessly via bluetooth to patient’s smartphones, providing real-time access to cardiac performance data for healthcare professionals.
   
• Additionally, cardiac monitoring devices offer continuous, real-time tracking of heart rhythms, heart rate, and other vital cardiac metrics. This help to detect any unusual heart activity quickly and allows for quick medical intervention if needed.
   
• Further, these cardiac monitoring devices continuously monitor heart activity and early signs of conditions such as irregular heartbeats, atrial fibrillation, and heart attacks. Thus, early detection improves the chances of successful treatment and minimizes the risk of serious complications. Thus, this helps in accelerating market growth.
   

Based on application, the remote patient monitoring devices market is bifurcated into cardiovascular diseases, cancer, diabetes, neurological disorders, infectious diseases respiratory diseases and other applications. The diabetes segment dominated the market with 22.7% market share in 2024.
 

• The increasing prevalence of diabetes has significantly created the demand for remote patient monitoring devices. For instance, according to the International Diabetes Federation (IDF), in 2024, approximately 589 million adults aged 20–79 years were living with diabetes worldwide. This number is projected to rise significantly, reaching an estimated 853 million by 2050, underscoring the growing global burden of the disease.
   
• Further, diabetes management requires continuous monitoring of key health metrics, including blood glucose levels, HbA1c, and insulin administration. Thus, to tackle this, RPM devices provide continuous real-time monitoring, allowing for better glucose control.
   
• Additionally, RPM devices help in the early detection of potential complications associated with diabetes such as hypoglycemia, hyperglycemia, and others. This early detection permits timely intervention, potentially preventing severe outcomes and hospitalizations, further contributing to the growth of the market.
   

Based on end use, the remote patient monitoring devices market is bifurcated into home-care settings, long-term care, and other end users. The home-care settings segment dominated the market in 2024 and is anticipated to witness growth at a CAGR of 13.7%.
 

• The growing prevalence of chronic disorders globally, such as cardiovascular diseases, diabetes, cancer, among others are creating a demand for effective convenient remote patient monitoring devices for home use.
   
• Advanced RPM devices help patients by providing real time data and alerts and continuous tracking of vital signs, thus making home care a better and easier option for the patients.
   
• New technological innovations in RPM devices have made them more accurate, comfortable and easy to use, which is encouraging more individuals to adopt them. Many RPM devices have ability to connect to smartphones and other digital devices or apps, which also makes it easier to track the data and to share it with healthcare providers.
   
• For example, KardiaMobile by AliveCor is a personal electrocardiogram device that records heart activity and transfers the data to smartphone app, this enables the users to monitor their health at home.
   
• Furthermore, due to the COVID-19 pandemic the adoption of homebased healthcare solutions such as RPM devices has increased. Since people desire to avoid hospital visit and limit the exposure to healthcare settings, RPM systems have become even more important for managing chronic conditions such as CVD’s, diabetes, etc. at home, which aids to propel market growth.
   

North America remote patient monitoring devices market dominated the global market with a market share of 40% in 2024. The market is driven by rising incidence of chronic diseases such as diabetes, cardiovascular diseases, along with an increasing emphasis on home-based care. Advancements in wearable sensors, mobile health application and a growing focus on early and accurate diagnosis also support market growth.
 

The U.S. market was valued at USD 5.6 billion and USD 5.5 billion in 2021 and 2022, respectively. The market size reached USD 6.3 billion in 2024, growing from USD 5.9 billion in 2023. 
 

• This growth is largely attributed due to the rising prevalence of chronic condition such as cardiovascular diseases, hypertension, and diabetes in the country.
   
• For instance, in 2021, as per the data from the Centers for Disease Control and Prevention (CDC) approximately 38.4 million individuals across the U.S. had diabetes which is equivalent to 11.6% of the total population. Furthermore, between 2021-2023, around 47.7% of adult population including older individuals were diagnosed with hypertension across the U.S.
   
• Thus, the remote patient monitoring devices such as smart blood pressure monitors, remote ECG devices, and pulse oximeters, facilities continuous monitoring of these chronic conditions in real time, thereby propelling the market growth.
   

Europe remote patient monitoring devices market accounted for USD 4.3 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising prevalence of chronic diseases in the region, coupled with the increasing government initiatives to enhance healthcare infrastructure is anticipated to spur the growth of the market.
   
• Moreover, advancements in remote patient monitoring devices, such as wearable sensors, blood glucose monitoring devices, and other devices for accurate diagnosis are boosting the growth of market in the Europe region.
   
• Also, the presence of key market players in the region reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative solutions, thereby aiding to the market growth.
   

Germany remote patient monitoring devices market is anticipated to witness considerable growth over the analysis period.
 

• The growth of remote patient monitoring devices market in this country is anticipated to bolster by the rising cases of chronic condition such as cardiovascular diseases, hypertension, and diabetes in Germany.
   
• For instance, according to the International Diabetes Federation (IDF), 6.2 million people in the Germany were living with diabetes in 2021, additionally nearly 10% of prevalence of diabetes was in adults.
   
• Further, the growth of market in this region is anticipated to be strengthened by the commitment of government in Germany towards tacking chronic condition via initiatives such as public health campaigns and guidelines that promotes healthier lifestyle. This is further contributing to the market growth.
   

The Asia Pacific remote patient monitoring devices market is anticipated to grow at the CAGR of 14.2% during the analysis timeframe.
 

• The market in the Asia Pacific region is expanding rapidly due to the growing burden of chronic diseases, rising health awareness, and continuous advancements in remote patient monitoring devices.
   
• Countries such as China, India and Japan are adopting remote patient monitoring technology driven by growing demand for advanced diagnostic solutions and expanding access to healthcare services.
   
• Additionally, rapid growth in the number of hospitals and diagnostic centers along with government policies aimed at improving diagnostic capabilities is further contributing to the growth of the market in the region.
   

China remote patient monitoring devices market is predicted to grow significantly over the forecast period.
 

• The country has one of rapidly increasing aging population which necessities frequent health monitoring.
   
• For instance, as per the estimates from World Health Organization in 2019, approximately 254 million people of age group 65 and above were residing in the country. This number is projected to rise significantly, with 402 million people expected to be over the age of 60 by 2040.
   
• The individuals of these age group are at high risk of developing chronic health condition such as diabetes, cardiovascular diseases, cancer, neurological disorders among others, which in turn necessities the need for advanced remote patient monitoring devices enable continuous health and early detection of complications, supports proactive disease management, which significantly contributes to the growth of the market.
   

Brazil is experiencing significant growth in the Latin America remote patient monitoring devices market due to the increasing demand for advanced remote patient monitoring devices.   
 

• The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, neurological disorders, and other are contributing to the growth of the market in the country.
   
• For instance, according to the Brazilian National Health Survey in 2019, there were approximately 12.95 million individuals diagnosed with cardiovascular disease (CVD) in Brazil, with 51% of the affected population being male.
   
• Additionally, there has been growing awareness about the benefits of early disease detection and prevention, driven by public health initiatives and education campaigns, which is encouraging individuals to undergo health check-ups. This trend is expected to foster market growth through 2034.
   

Saudi Arabia remote patient monitoring devices market is poised to witness substantial growth in Middle East and Africa market during the forecast period. 
 

• The government of Saudi Arabia is significantly investing in the healthcare infrastructure, to incorporate advanced medical devices such remote patient monitoring devices within the hospitals setting to provide utmost care to the individuals suffering from the chronic condition in the country.
   
• According to the Saudi Ministry of Health, in 2023, the government had allocated around USD 50.4 billion budget for healthcare infrastructure and social development.
   
• Moreover, the rising awareness regarding the benefits of RPM devices and physical fitness across various age group of individuals in the country, further propells the market growth.
   

Remote Patient Monitoring Devices Market Share

The top 4 players of the market account for approximately 40% of the market share which includes companies such as Abbott Laboratories, Boston Scientific, Koninklijke Philips, and Medtronic among others. These companies maintain their dominance in the market through innovative product launches, extensive distribution networks and strong regulatory approval. Moreover, strategic partnerships with research institutes, and government agencies play a primary role in advancing the development of advanced remote patient monitoring devices and getting the necessary permits. The development of public awareness about chronic diseases and its health impact through the social media platform, is expected to encourage more individuals to seek the treatment, enabling market players to strengthen their position in this growing sector.
 

Remote Patient Monitoring Devices Market Companies

Some of the eminent market participants operating in the remote patient monitoring devices industry include:

• Abbott Laboratories
• Baxter International
• Boston Scientific
• Cerner
• DexCom
• F. Hoffmann-La Roche
• General Electric Company
• Johnson & Johnson
• Koninklijke Philips
• Medtronic
• OMRON
• Siemens Healthineers         
• VitalConnect
   
• Boston Scientific has strong product portfolio leading to larger adoption and significant market expansion. Boston specializes in implantable cardiac monitoring solutions, such as LATITUDE, a remote patient monitoring system.
   
• Koninklijke Philips invests in research & development, fostering innovation and growth. The company continuously evolves with newest advancement in RPM devices.
   
• Medtronic has strong geographical presence which enables it to enhance its market reach. Medtronic operates in more than 150 countries thus comprising of a robust distribution network.
   

Remote Patient Monitoring Devices Industry News:

• In October 2023, VitalConnect partnered with Fifth Eye, to enhance its remote patient monitoring solutions by integrating Fifth Eye’s AHI system, the only FDA cleared software used to detect hemodynamic instability before the vital signs indicate deterioration. Thus, this partnership strengthened the company’s position in the industry.
   
• In August 2022, Medtronic formed a strategic partnership with BioIntelliSense for exclusive U.S. distribution rights of the BioButton wearable, supporting continuous, connected monitoring. This partnership increased Medtronic's remote monitoring capabilities and enhanced its market presence.
   
• In November 2022, Boston Scientific launched the LUX-Dx Insertable Cardiac Monitor (ICM) System in Europe, a device for detecting arrhythmias. This expansion strengthened its cardiac monitoring portfolio and competitive position in the European market.
   

The remote patient monitoring devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Cardiac monitoring devices
• Blood pressure monitoring devices
• Neurological monitoring devices
• Respiratory monitoring devices
• Multiparameter monitoring devices
• Blood glucose monitoring devices
• Fetal and neonatal monitoring devices
• Sleep monitoring devices
• Other monitoring devices

Market, By Application

• Cardiovascular diseases
• Cancer
• Diabetes
• Neurological disorders
• Infectious diseases
• Respiratory diseases
• Other applications

Market, By End Use

• Home-care settings
• Long-term care
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel